Skip to content
DiviCompasshome

Stock research

Merck & Company, Inc. Common Stock (new) (MRK) dividends

MRK on New York Stock Exchange, Health Care

$137.78 -3.90% on previous close. Close on 18 Nov 2026, in USD

Sign in to get an email when it declares a dividend.

Trailing yield2.47%Regular dividends, last 12 months
Forward yield (estimate)2.60%High confidence
Next 12 months per share (USD)$3.5841Quarterly
5-year dividend growth+5.8% a year15 years of increases
Payout ratio45%Year to 31 Dec 2025
Free cash flow cover1.5×Financial health: Strong

Merck & Company, Inc. Common Stock (new) dividend: key facts

Next dividend Estimate $0.8960 Ex-div about 15 Dec 2026 · Paid about 8 Jan 2027
Last dividend Quarterly $0.85 Ex-div 15 Sep 2026 · Paid 7 Oct 2026
How often Quarterly 4 payments a year
Dividend yield 2.47% Last 12 months · Forward 2.60%
Dividend growth +5.8% a year 5-year average · 15 years of increases
52-week yield range2.26% – 2.47%
Market cap$341bn
Shares in issue2,472m
Listed onNew York Stock Exchange · S&P 500

Own Merck & Company, Inc. Common Stock (new)? See exactly what it will pay you

Add your shares to a free DiviCompass portfolio to see your next MRK dividend in your own money, every payment month by month, and an email when it declares. Free for up to 10 holdings, no card needed.

Price history

End-of-day closes on New York Stock Exchange in USD. Dots mark ex-dividend dates.

Dividend history

Declared dividends. Special dividends are marked and excluded from yield and forecasts.

2018
1.99
2019
2.26
2020
2.48
2021
2.64
2022
2.8
2023
2.96
2024
3.12
2025
3.28
Ex-dividendPaymentPer shareCurrencyType
15 Sep 2026 Paid 7 Oct 2026 $0.85 USD Quarterly
15 Jun 2026 Paid 8 Jul 2026 $0.85 USD Quarterly
16 Mar 2026 Paid 7 Apr 2026 $0.85 USD Quarterly
15 Dec 2025 Paid 8 Jan 2026 $0.85 USD Quarterly
15 Sep 2025 Paid 7 Oct 2025 $0.81 USD Quarterly
16 Jun 2025 Paid 8 Jul 2025 $0.81 USD Quarterly
17 Mar 2025 Paid 7 Apr 2025 $0.81 USD Quarterly
16 Dec 2024 Paid 8 Jan 2025 $0.81 USD Quarterly
16 Sep 2024 Paid 7 Oct 2024 $0.77 USD Quarterly
17 Jun 2024 Paid 8 Jul 2024 $0.77 USD Quarterly
14 Mar 2024 Paid 5 Apr 2024 $0.77 USD Quarterly
14 Dec 2023 Paid 8 Jan 2024 $0.77 USD Quarterly
14 Sep 2023 Paid 6 Oct 2023 $0.73 USD Quarterly
14 Jun 2023 Paid 10 Jul 2023 $0.73 USD Quarterly
14 Mar 2023 Paid 10 Apr 2023 $0.73 USD Quarterly
14 Dec 2022 Paid 9 Jan 2023 $0.73 USD Quarterly
14 Sep 2022 Paid 7 Oct 2022 $0.69 USD Quarterly
14 Jun 2022 Paid 8 Jul 2022 $0.69 USD Quarterly
14 Mar 2022 Paid 7 Apr 2022 $0.69 USD Quarterly
14 Dec 2021 Paid 7 Jan 2022 $0.69 USD Quarterly
14 Sep 2021 Paid 7 Oct 2021 $0.65 USD Quarterly
14 Jun 2021 Paid 7 Jul 2021 $0.65 USD Quarterly
12 Mar 2021 Paid 7 Apr 2021 $0.65 USD Quarterly
14 Dec 2020 Paid 8 Jan 2021 $0.65 USD Quarterly

Five-year outlook

Estimates, not forecasts of what will be paid: dividends can be cut at any time.

PeriodPer shareCurrencyYield at today's priceConfidence
Next 12 months$3.5841USD2.60%High
Year 2$3.7782USD2.74%Medium
Year 3$3.9829USD2.89%Medium
Year 4$4.1986USD3.05%Low
Year 5$4.4259USD3.21%Low

How we got these figures. Raised 15 years in a row; grown at 5.4% a year (its recent pace).

With no growth at all, each year would be $3.40.

Reported financials

Annual figures from filings, converted to units.

Year toRevenueNet incomeEPSFree cash flowSource
31 Dec 2025US-GAAP USD $65.01bn $18.25bn $7.28 $12.36bnDerived Source (opens in a new tab)
31 Dec 2024US-GAAP USD $64.17bn $17.12bn $6.74 $18.10bnDerived Source (opens in a new tab)
31 Dec 2023US-GAAP USD $60.12bn $365.0m $0.14 $9.14bnDerived Source (opens in a new tab)
31 Dec 2022US-GAAP USD $59.28bn $14.52bn $5.71 $14.71bnDerived Source (opens in a new tab)
31 Dec 2021US-GAAP USD $48.70bn $13.05bn $5.14 $8.67bnDerived Source (opens in a new tab)
31 Dec 2020US-GAAP USD $47.99bn $7.07bn $2.78 $5.57bnDerived Source (opens in a new tab)

About Merck & Company, Inc. Common Stock (new)

Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue. The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda (pembrolizumab), a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products. The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000. In 1891, Merck & Co.

From Wikipedia, CC BY-SA 4.0.

Next 12 months

15 Dec 2026Ex-dividendUSD$0.8960Estimate
16 Mar 2027Ex-dividendUSD$0.8960Estimate
15 Jun 2027Ex-dividendUSD$0.8960Estimate
15 Sep 2027Ex-dividendUSD$0.8960Estimate

Estimate confidence: High

Financial health

A summary of the scores below, each 0 to 100. Based on the year to 31 Dec 2025.

Payout ratio
100
Cash cover
80
Debt
70
Track record
100

Company news

Dividend data and price last updated 18 Nov 2026.